The Clinical Application of Artificial Intelligence Assisted Renal Biopsy Diagnosis System.
Recruiting now
Conditions studied: Chronic Glomerulonephritis, Chronic Kidney Disease
In brief
This research project aims to collect images from patients with chronic glomerulonephritis. For each subject, the images obtained from renal biopsy will undergo evaluation by both the diagnostic model and the 'gold standard' diagnosis by pathologists. The researchers will test the subjects using the diagnostic model and compare the results with the known 'gold standard' diagnosis, in order to evaluate the AUC, specificity, and sensitivity of the diagnostic model.
Key facts
- Study ID
- NCT07330362
- Run by
- Zhujiang Hospital
- People needed
- 2900
- Starts
- 2024-07-01
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-01-27
Who can join
Age: 15 and older, up to 79. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Voluntary signing of informed consent form;
- Patients clinically diagnosed or suspected of having chronic kidney disease according to the 2023 KDIGO Clinical Practice Guideline for the Evaluation and Management of Kidney Disease;
- Undergoing renal biopsy and pathological specimen preparation.
You may not qualify if…
- Biopsy tissue from donor kidney or transplanted kidney;
- Poor quality of pathological specimen, unable to conduct pathological diagnosis.
Where it is running
- Nanfang Hospital — Guangzhou, Guangdong, China (enrolling)
- Zhujiang Hospital of Southern Medical University — Guangzhou, Guangdong, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.